Crossmark

Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019

Crossref DOI link: https://doi.org/10.1002/sctm.20-0083

Published Online: 2020-04-22

Published Print: 2020-07-01

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Ji, Fanpu

Li, Liya

Li, Zongfang

Jin, Yan

Liu, Wenjia
Funding

Funding for this research was provided by:

Fundamental Research Funds for the Central Universities for COVID-19 (xzy032020040)

Fundamental Research Funds for the Central Universities for COVID-19 (xzy032020040)
License Information

Version of Record valid from 2021-11-03

Version of Record valid from 2020-04-22

Text and Data Mining valid from 2020-04-22
More Information

Publication History

Received: 2020-02-27

Accepted: 2020-03-21

Published: 2020-04-22